4/23
08:12 am
phge
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) [Yahoo! Finance]
High
Report
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) [Yahoo! Finance]
4/23
08:00 am
phge
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
High
Report
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)
4/18
08:00 am
phge
BiomX Announces the Appointment of Susan Blum to its Board of Directors
Low
Report
BiomX Announces the Appointment of Susan Blum to its Board of Directors
4/4
09:57 am
phge
BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
BiomX Inc. (AMEX:PHGE) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
4/4
07:49 am
phge
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
Medium
Report
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure
4/3
06:52 am
phge
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
4/3
06:30 am
phge
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Medium
Report
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
3/27
06:30 am
phge
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
Low
Report
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024
3/19
05:12 am
phge
Telum Therapeutics appoints Dr. Subhendu Basu as CEO [Yahoo! Finance]
Medium
Report
Telum Therapeutics appoints Dr. Subhendu Basu as CEO [Yahoo! Finance]
3/19
05:00 am
phge
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
Medium
Report
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
3/19
05:00 am
phge
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
Medium
Report
Telum Therapeutics appoints Dr. Subhendu Basu as CEO
3/18
06:35 am
phge
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing [Yahoo! Finance]
High
Report
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing [Yahoo! Finance]
3/18
06:30 am
phge
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
Low
Report
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
3/11
09:31 am
phge
Thinking about buying stock in Marpai, Axcelis Technologies, Amylyx Pharmaceuticals, Biomx, or X4 Pharmaceuticals?
Low
Report
Thinking about buying stock in Marpai, Axcelis Technologies, Amylyx Pharmaceuticals, Biomx, or X4 Pharmaceuticals?
3/7
09:31 am
phge
Thinking about buying stock in Mirum Pharmaceuticals, Entera Bio, Andean Precious Metals, Viatris, or Biomx?
High
Report
Thinking about buying stock in Mirum Pharmaceuticals, Entera Bio, Andean Precious Metals, Viatris, or Biomx?
3/7
03:45 am
phge
Shareholder Alert: Ademi LLP investigates the transaction between BiomX Inc. and Adaptive Phage Therapeutics
High
Report
Shareholder Alert: Ademi LLP investigates the transaction between BiomX Inc. and Adaptive Phage Therapeutics